BZPEERReading, trust and collaboration for research
Menu

Discover

GraphFollow connections around a paper, topic or saved view.

Workspaces

HomePick up where your research flow left off.InboxHandle requests, replies and notifications from one place.CollectionsCurate reading lists, evidence sets and shareable dossiers.ResearchSee your private provenance graph, trail and imports.CollaborationMove from discovery into focused discussion rooms.PublishDraft, preview and publish full-text research articles.

Network

ExpertsFind specialists worth following or asking for help.CommunitiesJoin research circles organized around shared work.PartnersSee external organizations active around the same topics.

Opportunities

ListingsBrowse roles, calls and collaborations with clearer fit signals.

Account

Log inReturn to your reading and collaboration workspace.Create accountStart saving work, following people and joining teams.
Log inCreate account

Researcher profile

Charles F. Manski

Charles F. Manski contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate
econ.EMApplicationsMethodologyphysics.soc-phQuantitative Methodsstat.OT

Trust snapshot

Quick read

Trust 21 - EmergingVerification L1Unclaimed author
7works
0followers
6topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

7 published item(s)

preprint2022arXiv

Inference with Imputed Data: The Allure of Making Stuff Up

Incomplete observability of data generates an identification problem. There is no panacea for missing data. What one can learn about a population parameter depends on the assumptions one finds credible to maintain. The credibility of assumptions varies with the empirical setting. No specific assumptions can provide a realistic general solution to the problem of inference with missing data. Yet Rubin has promoted random multiple imputation (RMI) as a general way to deal with missing values in public-use data. This recommendation has been influential to empirical researchers who seek a simple fix to the nuisance of missing data. This paper adds to my earlier critiques of imputation. It provides a transparent assessment of the mix of Bayesian and frequentist thinking used by Rubin to argue for RMI. It evaluates random imputation to replace missing outcome or covariate data when the objective is to learn a conditional expectation. It considers steps that might help combat the allure of making stuff up.

0 citations0 reviewsNo code linkedOpen access
preprint2022arXiv

Minimax-Regret Climate Policy with Deep Uncertainty in Climate Modeling and Intergenerational Discounting

Integrated assessment models have become the primary tools for comparing climate policies that seek to reduce greenhouse gas emissions. Policy comparisons have often been performed by considering a planner who seeks to make optimal trade-offs between the costs of carbon abatement and the economic damages from climate change. The planning problem has been formalized as one of optimal control, the objective being to minimize the total costs of abatement and damages over a time horizon. Studying climate policy as a control problem presumes that a planner knows enough to make optimization feasible, but physical and economic uncertainties abound. Earlier, Manski, Sanstad, and DeCanio proposed and studied use of the minimax-regret (MMR) decision criterion to account for deep uncertainty in climate modeling. Here we study choice of climate policy that minimizes maximum regret with deep uncertainty regarding both the correct climate model and the appropriate time discount rate to use in intergenerational assessment of policy consequences. The analysis specifies a range of discount rates to express both empirical and normative uncertainty about the appropriate rate. The findings regarding climate policy are novel and informative. The MMR analysis points to use of a relatively low discount rate of 0.02 for climate policy. The MMR decision rule keeps the maximum future temperature increase below 2C above the 1900-10 level for most of the parameter values used to weight costs and damages.

0 citations0 reviewsNo code linkedOpen access
preprint2022arXiv

Patient-Centered Appraisal of Race-Free Clinical Risk Assessment

Until recently, there has been a consensus that clinicians should condition patient risk assessments on all observed patient covariates with predictive power. The broad idea is that knowing more about patients enables more accurate predictions of their health risks and, hence, better clinical decisions. This consensus has recently unraveled with respect to a specific covariate, namely race. There have been increasing calls for race-free risk assessment, arguing that using race to predict patient outcomes contributes to racial disparities and inequities in health care. Writers calling for race-free risk assessment have not studied how it would affect the quality of clinical decisions. Considering the matter from the patient-centered perspective of medical economics yields a disturbing conclusion: Race-free risk assessment would harm patients of all races.

0 citations0 reviewsNo code linkedOpen access
preprint2021arXiv

Econometrics For Decision Making: Building Foundations Sketched By Haavelmo And Wald

Haavelmo (1944) proposed a probabilistic structure for econometric modeling, aiming to make econometrics useful for decision making. His fundamental contribution has become thoroughly embedded in subsequent econometric research, yet it could not answer all the deep issues that the author raised. Notably, Haavelmo struggled to formalize the implications for decision making of the fact that models can at most approximate actuality. In the same period, Wald (1939, 1945) initiated his own seminal development of statistical decision theory. Haavelmo favorably cited Wald, but econometrics did not embrace statistical decision theory. Instead, it focused on study of identification, estimation, and statistical inference. This paper proposes statistical decision theory as a framework for evaluation of the performance of models in decision making. I particularly consider the common practice of as-if optimization: specification of a model, point estimation of its parameters, and use of the point estimate to make a decision that would be optimal if the estimate were accurate. A central theme is that one should evaluate as-if optimization or any other model-based decision rule by its performance across the state space, listing all states of nature that one believes feasible, not across the model space. I apply the theme to prediction and treatment choice. Statistical decision theory is conceptually simple, but application is often challenging. Advancement of computation is the primary task to continue building the foundations sketched by Haavelmo and Wald.

0 citations0 reviewsNo code linkedOpen access
preprint2020arXiv

Estimating the COVID-19 Infection Rate: Anatomy of an Inference Problem

As a consequence of missing data on tests for infection and imperfect accuracy of tests, reported rates of population infection by the SARS CoV-2 virus are lower than actual rates of infection. Hence, reported rates of severe illness conditional on infection are higher than actual rates. Understanding the time path of the COVID-19 pandemic has been hampered by the absence of bounds on infection rates that are credible and informative. This paper explains the logical problem of bounding these rates and reports illustrative findings, using data from Illinois, New York, and Italy. We combine the data with assumptions on the infection rate in the untested population and on the accuracy of the tests that appear credible in the current context. We find that the infection rate might be substantially higher than reported. We also find that the infection fatality rate in Italy is substantially lower than reported.

0 citations0 reviewsNo code linkedOpen access
preprint2020arXiv

Statistical Decision Properties of Imprecise Trials Assessing COVID-19 Drugs

As the COVID-19 pandemic progresses, researchers are reporting findings of randomized trials comparing standard care with care augmented by experimental drugs. The trials have small sample sizes, so estimates of treatment effects are imprecise. Seeing imprecision, clinicians reading research articles may find it difficult to decide when to treat patients with experimental drugs. Whatever decision criterion one uses, there is always some probability that random variation in trial outcomes will lead to prescribing sub-optimal treatments. A conventional practice when comparing standard care and an innovation is to choose the innovation only if the estimated treatment effect is positive and statistically significant. This practice defers to standard care as the status quo. To evaluate decision criteria, we use the concept of near-optimality, which jointly considers the probability and magnitude of decision errors. An appealing decision criterion from this perspective is the empirical success rule, which chooses the treatment with the highest observed average patient outcome in the trial. Considering the design of recent and ongoing COVID-19 trials, we show that the empirical success rule yields treatment results that are much closer to optimal than those generated by prevailing decision criteria based on hypothesis tests.

0 citations0 reviewsNo code linkedOpen access
preprint2013arXiv

Treatment Choice in Heterogeneous Populations Using Experiments without Covariate Data (Invited Paper)

I examine the problem of treatment choice when a planner observes (i) covariates that describe each member of a population of interest and (ii) the outcomes of an experiment in which subjects randomly drawn from this population are randomly assigned to treatment groups within which all subjects receive the same treatment. Covariate data for the subjects of the experiment are not available. The optimal treatment rule is to divide the population into subpopulations whose members share the same covariate value, and then to choose for each subpopulation a treatment that maximizes its mean outcome. However the planner cannot implement this rule. I draw on my work on nonparametric analysis of treatment response to address the planner's problem.

0 citations0 reviewsNo code linkedOpen access